Medios AG (LON:0QB4)

Market Cap	278.35M
Revenue (ttm)	1.60B
Net Income (ttm)	12.50M
Shares Out	n/a
EPS (ttm)	0.49
PE Ratio	22.27
Forward PE	12.53
Dividend	n/a
Ex-Dividend Date	n/a

Volume	129
Average Volume	325
Open	12.48
Previous Close	12.82
Day's Range	12.20 - 12.64
52-Week Range	10.20 - 18.42
Beta	1.17
RSI	54.25
Earnings Date	Aug 13, 2025

About Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. The company operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 2016
• Employees: 952
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QB4

Financial Performance

In 2024, Medios AG's revenue was 1.88 billion, an increase of 5.51% compared to the previous year's 1.78 billion. Earnings were 12.55 million, a decrease of -33.29%.

Financial numbers in EUR